Tubing determination in an hematology oncology clinic

J Oncol Pharm Pract. 2021 Jul;27(5):1186-1188. doi: 10.1177/10781552211013092. Epub 2021 May 6.

Abstract

United States Pharmacopeia (USP) Chapter <800> for hazardous drug (HD) handling in healthcare settings requires HD be primed intravenously with a non-HD solution prior to dispensing. This review details our clinic's algorithm for determining tubing needs for medications used in an hematology oncology clinic. Factors to consider are volume, irritant and vesicant properties, and compatibility with hydration solution.

Keywords: Chemotherapy; priming; usp800.

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Hazardous Substances / administration & dosage
  • Hematologic Neoplasms / drug therapy*
  • Hematology
  • Humans
  • Medical Oncology

Substances

  • Antineoplastic Agents
  • Hazardous Substances